Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000428 | DNA-directed RNA polymerase complex | 4 | 10 |
GO:0030880 | RNA polymerase complex | 3 | 10 |
GO:0032991 | protein-containing complex | 1 | 10 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 4 | 10 |
GO:0140535 | intracellular protein-containing complex | 2 | 10 |
GO:1902494 | catalytic complex | 2 | 10 |
GO:1990234 | transferase complex | 3 | 10 |
GO:0005666 | RNA polymerase III complex | 4 | 1 |
GO:0016020 | membrane | 2 | 1 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: A0A3Q8I7I6
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 10 |
GO:0006352 | DNA-templated transcription initiation | 6 | 10 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 10 |
GO:0006807 | nitrogen compound metabolic process | 2 | 10 |
GO:0008152 | metabolic process | 1 | 10 |
GO:0009058 | biosynthetic process | 2 | 10 |
GO:0009059 | macromolecule biosynthetic process | 4 | 10 |
GO:0009987 | cellular process | 1 | 10 |
GO:0016070 | RNA metabolic process | 5 | 10 |
GO:0018130 | heterocycle biosynthetic process | 4 | 10 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 10 |
GO:0032774 | RNA biosynthetic process | 5 | 10 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 10 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 10 |
GO:0043170 | macromolecule metabolic process | 3 | 10 |
GO:0044237 | cellular metabolic process | 2 | 10 |
GO:0044238 | primary metabolic process | 2 | 10 |
GO:0044249 | cellular biosynthetic process | 3 | 10 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 10 |
GO:0046483 | heterocycle metabolic process | 3 | 10 |
GO:0071704 | organic substance metabolic process | 2 | 10 |
GO:0090304 | nucleic acid metabolic process | 4 | 10 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 10 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 10 |
GO:1901576 | organic substance biosynthetic process | 3 | 10 |
GO:0006384 | transcription initiation at RNA polymerase III promoter | 7 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 202 | 206 | PF00656 | 0.243 |
CLV_C14_Caspase3-7 | 25 | 29 | PF00656 | 0.482 |
CLV_C14_Caspase3-7 | 258 | 262 | PF00656 | 0.355 |
CLV_C14_Caspase3-7 | 264 | 268 | PF00656 | 0.295 |
CLV_C14_Caspase3-7 | 53 | 57 | PF00656 | 0.526 |
CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.586 |
CLV_PCSK_SKI1_1 | 65 | 69 | PF00082 | 0.456 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.493 |
DEG_SPOP_SBC_1 | 218 | 222 | PF00917 | 0.305 |
DOC_CDC14_PxL_1 | 146 | 154 | PF14671 | 0.355 |
DOC_PP4_FxxP_1 | 151 | 154 | PF00568 | 0.282 |
DOC_USP7_MATH_1 | 104 | 108 | PF00917 | 0.458 |
DOC_USP7_MATH_1 | 218 | 222 | PF00917 | 0.409 |
DOC_USP7_MATH_1 | 27 | 31 | PF00917 | 0.430 |
DOC_USP7_MATH_1 | 50 | 54 | PF00917 | 0.689 |
LIG_14-3-3_CanoR_1 | 163 | 171 | PF00244 | 0.326 |
LIG_14-3-3_CanoR_1 | 71 | 77 | PF00244 | 0.341 |
LIG_BIR_III_4 | 259 | 263 | PF00653 | 0.305 |
LIG_BIR_III_4 | 283 | 287 | PF00653 | 0.398 |
LIG_eIF4E_1 | 140 | 146 | PF01652 | 0.355 |
LIG_FHA_1 | 111 | 117 | PF00498 | 0.426 |
LIG_FHA_1 | 140 | 146 | PF00498 | 0.470 |
LIG_FHA_1 | 44 | 50 | PF00498 | 0.556 |
LIG_FHA_1 | 8 | 14 | PF00498 | 0.439 |
LIG_FHA_2 | 61 | 67 | PF00498 | 0.377 |
LIG_LIR_Gen_1 | 107 | 116 | PF02991 | 0.335 |
LIG_LIR_Gen_1 | 144 | 154 | PF02991 | 0.296 |
LIG_LIR_Nem_3 | 107 | 112 | PF02991 | 0.411 |
LIG_LIR_Nem_3 | 144 | 149 | PF02991 | 0.336 |
LIG_LIR_Nem_3 | 3 | 8 | PF02991 | 0.349 |
LIG_MYND_1 | 150 | 154 | PF01753 | 0.398 |
LIG_PDZ_Class_3 | 292 | 297 | PF00595 | 0.650 |
LIG_Pex14_2 | 18 | 22 | PF04695 | 0.548 |
LIG_SH2_CRK | 8 | 12 | PF00017 | 0.361 |
LIG_SH2_NCK_1 | 8 | 12 | PF00017 | 0.438 |
LIG_SH2_STAP1 | 60 | 64 | PF00017 | 0.529 |
LIG_SH2_STAP1 | 8 | 12 | PF00017 | 0.361 |
LIG_SH2_STAT5 | 140 | 143 | PF00017 | 0.379 |
LIG_SH2_STAT5 | 17 | 20 | PF00017 | 0.407 |
LIG_SH2_STAT5 | 172 | 175 | PF00017 | 0.398 |
LIG_SH2_STAT5 | 5 | 8 | PF00017 | 0.337 |
LIG_SH2_STAT5 | 76 | 79 | PF00017 | 0.360 |
LIG_SH3_3 | 115 | 121 | PF00018 | 0.370 |
LIG_SH3_3 | 13 | 19 | PF00018 | 0.390 |
LIG_SH3_3 | 144 | 150 | PF00018 | 0.398 |
LIG_SUMO_SIM_par_1 | 46 | 54 | PF11976 | 0.463 |
LIG_SUMO_SIM_par_1 | 9 | 14 | PF11976 | 0.316 |
LIG_TYR_ITIM | 6 | 11 | PF00017 | 0.365 |
MOD_CK1_1 | 162 | 168 | PF00069 | 0.355 |
MOD_CK1_1 | 217 | 223 | PF00069 | 0.342 |
MOD_CK1_1 | 250 | 256 | PF00069 | 0.403 |
MOD_CK1_1 | 39 | 45 | PF00069 | 0.587 |
MOD_CK1_1 | 97 | 103 | PF00069 | 0.535 |
MOD_CK2_1 | 252 | 258 | PF00069 | 0.393 |
MOD_CK2_1 | 286 | 292 | PF00069 | 0.355 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.373 |
MOD_GlcNHglycan | 164 | 167 | PF01048 | 0.469 |
MOD_GlcNHglycan | 184 | 188 | PF01048 | 0.155 |
MOD_GlcNHglycan | 201 | 204 | PF01048 | 0.292 |
MOD_GlcNHglycan | 216 | 219 | PF01048 | 0.432 |
MOD_GlcNHglycan | 254 | 257 | PF01048 | 0.417 |
MOD_GlcNHglycan | 263 | 266 | PF01048 | 0.311 |
MOD_GlcNHglycan | 267 | 270 | PF01048 | 0.401 |
MOD_GlcNHglycan | 28 | 32 | PF01048 | 0.587 |
MOD_GlcNHglycan | 38 | 41 | PF01048 | 0.687 |
MOD_GlcNHglycan | 42 | 45 | PF01048 | 0.672 |
MOD_GlcNHglycan | 95 | 99 | PF01048 | 0.452 |
MOD_GSK3_1 | 104 | 111 | PF00069 | 0.378 |
MOD_GSK3_1 | 210 | 217 | PF00069 | 0.315 |
MOD_GSK3_1 | 261 | 268 | PF00069 | 0.293 |
MOD_GSK3_1 | 32 | 39 | PF00069 | 0.581 |
MOD_N-GLC_1 | 35 | 40 | PF02516 | 0.555 |
MOD_N-GLC_2 | 24 | 26 | PF02516 | 0.538 |
MOD_N-GLC_2 | 57 | 59 | PF02516 | 0.485 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.370 |
MOD_NEK2_1 | 110 | 115 | PF00069 | 0.452 |
MOD_NEK2_1 | 214 | 219 | PF00069 | 0.418 |
MOD_NEK2_1 | 276 | 281 | PF00069 | 0.382 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.343 |
MOD_NEK2_1 | 94 | 99 | PF00069 | 0.431 |
MOD_NEK2_2 | 60 | 65 | PF00069 | 0.466 |
MOD_PKA_2 | 162 | 168 | PF00069 | 0.305 |
MOD_PKA_2 | 276 | 282 | PF00069 | 0.352 |
MOD_PKA_2 | 70 | 76 | PF00069 | 0.365 |
MOD_Plk_1 | 250 | 256 | PF00069 | 0.361 |
MOD_Plk_4 | 1 | 7 | PF00069 | 0.341 |
MOD_Plk_4 | 276 | 282 | PF00069 | 0.311 |
MOD_Plk_4 | 286 | 292 | PF00069 | 0.355 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.342 |
TRG_ENDOCYTIC_2 | 172 | 175 | PF00928 | 0.398 |
TRG_ENDOCYTIC_2 | 8 | 11 | PF00928 | 0.361 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P336 | Leptomonas seymouri | 55% | 90% |
A0A1X0NIF1 | Trypanosomatidae | 32% | 97% |
A4H5T5 | Leishmania braziliensis | 82% | 99% |
A4HU28 | Leishmania infantum | 99% | 100% |
D0A9K8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 100% |
E9AMV8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 92% | 100% |
Q4QHR8 | Leishmania major | 96% | 100% |
V5BI52 | Trypanosoma cruzi | 33% | 100% |